STOCK TITAN

Ensign Group Inc SEC Filings

ENSG NASDAQ

Welcome to our dedicated page for Ensign Group SEC filings (Ticker: ENSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Ensign Group, Inc. (Nasdaq: ENSG) files detailed reports with the U.S. Securities and Exchange Commission that describe its post-acute healthcare operations, skilled nursing and senior living services, and healthcare real estate activities. This SEC filings page brings together those documents, along with AI-powered tools that help explain the information they contain.

Ensign’s current reports on Form 8-K discuss topics such as quarterly financial results, the use of non-GAAP financial measures, and changes in board composition and executive roles. In these filings, the company explains how it calculates measures like Adjusted Net Income, Adjusted Earnings per Share, EBITDA, Adjusted EBITDA, Adjusted EBITDAR, Adjusted EBT and Funds from Operations (FFO) for its Standard Bearer real estate segment. These definitions help investors understand how Ensign evaluates performance in its skilled services and real estate businesses.

Through this page, users can access Ensign’s annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K as they are made available on EDGAR. AI-generated summaries highlight key points from lengthy filings, such as segment descriptions, the role of Standard Bearer Healthcare REIT, Inc., and the company’s approach to non-GAAP metrics. The platform also surfaces relevant information from Forms 3, 4 and 5 related to equity ownership and transactions by directors and officers, giving additional context on insider activity.

By combining real-time SEC updates with AI explanations, this ENSG filings page is intended to make Ensign’s regulatory disclosures more accessible to investors who want to understand its skilled nursing, senior living and healthcare real estate operations in greater depth.

Rhea-AI Summary

Keetch Chad reported acquisition or exercise transactions in this Form 4 filing.

Ensign Group executive Chad Keetch, the company’s CIO, EVP and Secretary, reported an equity award of 8,340 shares of common stock on February 18, 2026. The shares were valued at $209.96 each for reporting purposes. Following this grant or award, Keetch directly holds 102,754 common shares, aligning a portion of his compensation with shareholders through stock ownership rather than cash pay.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Ensign Group, Inc.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

ENSIGN GROUP, INC Chief Executive Officer and director Barry Port reported an equity award of 13,871 shares of common stock on February 18, 2026. The shares were granted at a price of $209.96 per share as a grant, award, or other acquisition, rather than an open-market purchase.

After this award, Port’s direct holdings increased to 70,352 common shares. He also reports indirect ownership of 150,480 common shares held "by Trust," with a footnote stating these shares are held of record by Barry R. Port and his spouse, Michelle Port, as trustees.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Marivic Uychiat filed a Form 144 reporting a proposed sale of 67 common shares of ENSG on 02/19/2026 tied to restricted stock vesting as compensation. The filing also records 83 common shares sold during the past three months on 02/19/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Ensign Group director Daren Shaw reported an open-market sale of 1,000 shares of Ensign Group common stock. The transaction occurred on February 17, 2026 at a price of $213.43 per share and was effected under a Rule 10b5-1 trading plan adopted on May 7, 2025. Following this sale, Shaw directly owns 23,726 shares of Ensign Group common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

ENSG filed a Form 144 proposing the sale of 500 common shares tied to options granted 02/19/2021, with the method listed as cash. The excerpt also shows prior sales by Beverly Wittekind: 8,400 shares on 12/12/2025 for $1,473,999.97 and 2,000 shares on 12/19/2025 for $360,000.00.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

An individual named Daren Shaw filed a notice of proposed sale of restricted or control securities under Rule 144. The filing covers 1,000 shares of common stock to be sold through Fidelity Brokerage Services LLC on the NASDAQ, with an aggregate market value of $213,430.00.

The shares come from multiple restricted stock vesting events between 2018 and January 2026, each received as compensation from the issuer. The filing also notes that Shaw sold 1,000 common shares on 11/18/2025 for $178,570.00 in gross proceeds during the prior three months.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Wasatch Advisors reports a significant institutional stake in Ensign Group Inc/The common stock. The firm beneficially owns 2,838,566 shares, representing 4.9% of the outstanding common stock as of 12/31/2025.

Wasatch Advisors has sole voting power over 1,865,171 shares and sole dispositive (selling) power over the full 2,838,566 shares, with no shared voting or dispositive authority. The firm certifies the position is held in the ordinary course of business and not to influence control of Ensign Group.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Summary

The Ensign Group director Ann Scott Blouin reported selling 375 shares of common stock on February 9, 2026. The shares were sold at a price of $198 per share under a pre-arranged Rule 10b5-1 trading plan adopted on November 7, 2025.

After this transaction, Blouin beneficially owned 22,852 Ensign Group shares, held in direct ownership. The filing reflects a planned, programmatic sale by a board member rather than a discretionary, one-time trade.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Ensign Group (ENSG)?

The current stock price of Ensign Group (ENSG) is $207.3 as of March 5, 2026.

What is the market cap of Ensign Group (ENSG)?

The market cap of Ensign Group (ENSG) is approximately 12.3B.

ENSG Rankings

ENSG Stock Data

12.32B
55.79M
Medical Care Facilities
Services-skilled Nursing Care Facilities
Link
United States
SAN JUAN CAPISTRANO

ENSG RSS Feed